Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Facet Biotech Has $722M That Says It Pays to Stand Up to Bullies
BNET Pharma
Thursday, March 11, 2010 - 10:59am
tags:
Facet Biotech, Biogen Idec, Abbott Laboratories, M&A
How Many Reps Visit A Doctor’s Office Each Week?
Pharmalot
Thursday, March 11, 2010 - 10:56am
tags:
sales reps, physicians
BioSante rallies on study; drug stocks slip
Marketwatch
Thursday, March 11, 2010 - 10:54am
tags:
BioSante, drug stocks
[video]Cramer: Abbott's a Growth Stock
TheStreet.com
Thursday, March 11, 2010 - 10:53am
tags:
Abbott Laboratories
FDA to Review Bone Drugs After Studies Report Hip Breaks
WSJ Online
Thursday, March 11, 2010 - 9:05am
tags:
FDA, osteoporosis, Merck, Fosamax
No+No=Yes: Pirfenidone and the Power of Orphan Drugs
InVivo
Thursday, March 11, 2010 - 9:04am
tags:
orphan drugs, pirfenidone, FDA, InterMune
StemCells pares 4Q loss after acquisition
Yahoo/AP
Thursday, March 11, 2010 - 9:01am
tags:
earnings, StemCells
10 Biotech Stocks On the Line
TheStreet.com
Thursday, March 11, 2010 - 8:57am
tags:
Medivation, InterMune, Allos, Affymax, Amylin, Alkermes, Cell Therapeutics, Delcath, Dendreon, GenVec, MannKind, Somaxon, Vertex Pharmaceuticals
Merck’s Stromectol Wipes Out Hard-to-Treat Lice, Study Finds
Bloomberg
Thursday, March 11, 2010 - 8:54am
tags:
Merck, lice, Stromectol
At Novartis, It's Pregnant Women vs. Cheerleaders Among the Sales Reps
BNET Pharma
Thursday, March 11, 2010 - 8:53am
tags:
sales reps, discrimination, Novartis, cafepharma
Did J&J Plan to Break Rules?
Businessweek
Thursday, March 11, 2010 - 8:51am
tags:
Risperdal, JNJ
Sanofi-aventis Successfully Completes The Acquisition of Chattem, Inc
Yahoo
Thursday, March 11, 2010 - 8:40am
tags:
Sanofi, M&A, Chattem
AstraZeneca Teams Up With India’s Torrent in Generics
Bloomberg
Thursday, March 11, 2010 - 8:37am
tags:
AstraZeneca, India, generics, Torrent Pharmaceuticals, partnerships
Drug Safety, Social Media & A Universal Symbol
Pharmalot
Thursday, March 11, 2010 - 8:36am
tags:
social media, drug safety, PhRMA
Obamacare? Who Cares? There Are Drug Deals To Do
WSJ Online
Thursday, March 11, 2010 - 8:32am
tags:
healthcare reform, M&A, Abbott Laboratories, Facet Biotech, Astellas, OSI Pharmaceuticals, Pfizer, Teva Pharmaceuticals, Ratiopharm
Chelsea Therapeutics 4Q loss narrows on costs
Yahoo/AP
Thursday, March 11, 2010 - 8:30am
tags:
Chelsea Therapeutics, earnings
Nabi Biopharmaceuticals logs revenue from Glaxo sale
Bizjournals.com
Thursday, March 11, 2010 - 8:30am
tags:
GSK, Nabi, PentaStaph, licensing.NicVAx
3 Biotech Stocks On The Move
Investopedia
Wednesday, March 10, 2010 - 11:18am
tags:
OSI Pharmaceuticals, InterMune, Medivation
Biotechs Jump on Facet, Intermune Deal
Barron's
Wednesday, March 10, 2010 - 11:17am
tags:
InterMune, Facet Biotech
A Tale Of Two Sectors
CNBC
Wednesday, March 10, 2010 - 11:08am
tags:
biotech, Big Pharma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.